MDT · News · 20260909N
Guidance / Outlook
Medtronic plc · 2026-09-09 · Importance 49 · Surprise 60 · In source text
Medtronic raised its fiscal 2027 organic revenue-growth outlook and increased the lower end of its adjusted earnings forecast. Management attributed the improved outlook to broad-based growth and stronger demand for cardiovascular devices, particularly pulsed-field ablation products. Third-party reporting said tariff uncertainty, competition, and the integration of acquisitions remain risks to sustaining the outlook.
Key facts
- Medtronic announced new investments in heart-valve technology and surgical robotics. source
- MDT lifts its 2027 outlook. source
- Medtronic has raised its fiscal 2027 organic revenue growth outlook. source
- Medtronic raised the lower end of its adjusted earnings forecast for fiscal 2027. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| operating_income | negative | probable | — | Medtronic announced new investments in heart-valve technology and surgical robotics. |
| revenue | positive | probable | — | Medtronic has raised its fiscal 2027 organic revenue growth outlook. |
| net_income | positive | probable | — | Medtronic raised the lower end of its adjusted earnings forecast for fiscal 2027. |